Eris Lifesciences Limited (NSE:ERIS)
1,518.90
+13.00 (0.86%)
May 22, 2025, 11:30 AM IST
Eris Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 21, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Market Capitalization | 205,081 | 192,990 | 114,719 | 77,801 | 93,615 | 82,147 | Upgrade
|
Market Cap Growth | 68.23% | 68.23% | 47.45% | -16.89% | 13.96% | 64.00% | Upgrade
|
Enterprise Value | 231,756 | 221,970 | 121,268 | 80,085 | 92,600 | 80,183 | Upgrade
|
Last Close Price | 1505.90 | 1417.35 | 838.59 | 568.87 | 677.58 | 590.51 | Upgrade
|
PE Ratio | 58.35 | 54.85 | 29.27 | 20.36 | 23.05 | 23.13 | Upgrade
|
Forward PE | 37.85 | 38.80 | 25.79 | 17.15 | 21.23 | 21.38 | Upgrade
|
PS Ratio | 7.04 | 6.63 | 5.76 | 4.68 | 7.06 | 6.89 | Upgrade
|
PB Ratio | 6.27 | 5.90 | 3.56 | 3.50 | 4.91 | 5.21 | Upgrade
|
P/TBV Ratio | - | - | - | - | 8.10 | 10.28 | Upgrade
|
P/FCF Ratio | 22.54 | 21.21 | 32.15 | - | 36.39 | 23.50 | Upgrade
|
P/OCF Ratio | 19.26 | 18.12 | 23.61 | 26.67 | 24.75 | 21.89 | Upgrade
|
PEG Ratio | 1.18 | 1.29 | 1.61 | 1.91 | 1.46 | 1.14 | Upgrade
|
EV/Sales Ratio | 7.96 | 7.62 | 6.09 | 4.82 | 6.98 | 6.72 | Upgrade
|
EV/EBITDA Ratio | 22.38 | 21.44 | 18.30 | 15.23 | 19.18 | 18.82 | Upgrade
|
EV/EBIT Ratio | 32.19 | 30.83 | 24.53 | 18.99 | 21.81 | 20.69 | Upgrade
|
EV/FCF Ratio | 25.47 | 24.39 | 33.98 | - | 36.00 | 22.94 | Upgrade
|
Debt / Equity Ratio | 0.76 | 0.76 | 0.86 | 0.40 | 0.05 | 0.01 | Upgrade
|
Debt / EBITDA Ratio | 2.39 | 2.39 | 4.13 | 1.66 | 0.19 | 0.04 | Upgrade
|
Debt / FCF Ratio | 2.72 | 2.72 | 7.79 | - | 0.36 | 0.05 | Upgrade
|
Asset Turnover | 0.41 | 0.41 | 0.37 | 0.56 | 0.65 | 0.70 | Upgrade
|
Inventory Turnover | 2.73 | 2.73 | 2.47 | 2.90 | 2.49 | 2.95 | Upgrade
|
Quick Ratio | 0.50 | 0.50 | 0.70 | 1.22 | 1.99 | 1.78 | Upgrade
|
Current Ratio | 0.89 | 0.89 | 0.91 | 1.73 | 3.14 | 2.80 | Upgrade
|
Return on Equity (ROE) | 11.54% | 11.54% | 14.59% | 18.12% | 23.29% | 24.72% | Upgrade
|
Return on Assets (ROA) | 6.39% | 6.39% | 5.77% | 8.87% | 12.92% | 14.31% | Upgrade
|
Return on Capital (ROIC) | 7.66% | 7.66% | 6.78% | 10.31% | 14.76% | 16.70% | Upgrade
|
Return on Capital Employed (ROCE) | 12.70% | 12.70% | 10.90% | 13.10% | 20.50% | 23.20% | Upgrade
|
Earnings Yield | 1.72% | 1.82% | 3.42% | 4.91% | 4.34% | 4.32% | Upgrade
|
FCF Yield | 4.44% | 4.71% | 3.11% | -7.07% | 2.75% | 4.26% | Upgrade
|
Dividend Yield | 0.50% | - | - | 1.29% | 0.89% | 0.93% | Upgrade
|
Payout Ratio | 28.44% | 28.44% | - | 26.14% | 20.10% | 21.03% | Upgrade
|
Buyback Yield / Dilution | -0.11% | -0.11% | -0.03% | -0.19% | -0.02% | 1.03% | Upgrade
|
Total Shareholder Return | 0.39% | -0.11% | -0.03% | 1.10% | 0.86% | 1.97% | Upgrade
|
Updated Feb 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.